Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 May 2;18(1):23.
doi: 10.5334/gh.1198. eCollection 2023.

Incidence, Risk Factors, Maternal and Neonatal Outcomes of Peripartum Cardiomyopathy (PPCM) in Oman

Nihal Al Riyami  1 , Safa Al Khayari  2 , Riham Al Zadjali  1 , Lovina Machado  3 , Alya Al Madhani  4 , Hatim Al Lawati  5
Affiliations

Incidence, Risk Factors, Maternal and Neonatal Outcomes of Peripartum Cardiomyopathy (PPCM) in Oman

Nihal Al Riyami et al. Glob Heart. .

Abstract

Background: Peripartum cardiomyopathy (PPCM) is an idiopathic life-threatening condition occurring towards the end of pregnancy or in the first few months following delivery that might affect the maternal and neonatal outcomes.

Objectives: To assess the incidence and to evaluate the antenatal risk factors and the maternal and neonatal outcomes in Omani women diagnosed with PPCM.

Methods: A retrospective cohort study was conducted at two tertiary institutions in Oman between the 1st of January 2010 to the 31st of December 2018. All cases fitting the standard definition of PPCM were included in the analysis. Patients with pre-existing dilated cardiomyopathy, chronic obstructive pulmonary disease and significant valvular heart disease have been excluded.

Results: A total of 113,104 deliveries were screened during the study period. PPCM was confirmed in 116 cases with an incidence of 1.02 per 1000 deliveries. Independent predictors for the development of PPCM were age; especially women at the mid reproductive age (26-35 years), singleton pregnancy and gestational hypertension. In general, maternal outcomes were favorable, with full recovery of left ventricular ejection fraction in 56.0%, recurrence of 9.2%, and an overall mortality rate of 3.4%. The most common maternal complication was pulmonary edema (16.3%). The neonatal mortality rate was 4.3% and the preterm birth rate was 35.7%. Neonatal outcomes included 94.3% live births, out of which 64.3% were term with Apgar scores of more than 7 at five minutes in 91.5% of the neonates.

Conclusion: Our study resulted in an overall incidence of PCCM in Oman of 1.02 in 1000 deliveries. Given the significance of maternal and neonatal complications, establishing a national PPCM database and local practice guidelines, and emphasizing their implementations in all regional hospitals, are fundamental for early recognition of the disease, timely referral, and application of therapy. Future studies, with a clearly defined control group, are highly recommended to appraise the significance of antenatal comorbidities in PPCM compared to non-PPCM cases.

Keywords: cardiomyopathies; heart failure; incidence; peripartum period; pregnancy.

PubMed Disclaimer

Conflict of interest statement

The authors have no competing interests to declare.

Figures

A linear graph demonstrating the incidence of PPCM in Oman in the period from
Figure 1
A linear graph demonstrating the incidence of PPCM in Oman in the period from.
See this image and copyright information in PMC

References

    1. Sliwa K, Hilfiker-Kleiner D. Peripartum cardiomyopathy [Internet]. In Camm AJ, Lüscher TF, Maurer G, Serruys PW (eds.), The ESC Textbook of Cardiovascular Medicine. Oxford University Press; 2018. DOI: 10.1093/med/9780198784906.003.0374 - DOI
    1. Kiriyama Y, Kinishi Y, Hiramatu D, Uchiyama A, Fujino Y, Toda K, et al. Outcomes of severe peripartum cardiomyopathy and mechanical circulatory support: A case series. JA Clin Reports [Internet]. 2021; 7(1): 4–8. DOI: 10.1186/s40981-021-00484-2 - DOI - PMC - PubMed
    1. Kim D-Y, Kim SR, Park S-J, Seo J-H, Kim EK, Yang JH, et al. Clinical characteristics and long-term outcomes of peripartum takotsubo cardiomyopathy and peripartum cardiomyopathy. ESC Hear Fail. 2020. Dec 1; 7(6): 3644. DOI: 10.1002/ehf2.12889 - DOI - PMC - PubMed
    1. Sliwa K, Bauersachs J, Arany Z, Spracklen TF, Hilfiker-Kleiner D. Peripartum cardiomyopathy: From genetics to management. In Bouhaddoune Y, Hbali A, Aissaoui H, Mrabet A, Ismaili N (eds.), Eur Heart. 2021. Aug 21; 42(32): 3094–3102. Article Case series. DOI: 10.1093/eurheartj/ehab458 - DOI - PubMed
    1. Hoes MF, Arany Z, Bauersachs J, Hilfiker-Kleiner D, Petrie MC, Sliwa K, et al. Pathophysiology and risk factors of peripartum cardiomyopathy. Nat Rev Cardiol. 2022; 19(8): 555–565. DOI: 10.1038/s41569-021-00664-8 - DOI - PubMed